FOLD - AMICUS THERAPEUTICS, INC.
IEX Last Trade
9.58
-0.055 -0.574%
Share volume: 14,662
Last Updated: Fri 27 Dec 2024 05:30:03 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$9.64
-0.06
-0.57%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-07 | 2023-03-01 | 2023-05-10 | 2023-08-08 | 2023-11-08 | 2024-02-28 | 2024-05-09 | |
| Total revenue | 80.731 M | 81.691 M | 88.096 M | 86.270 M | 94.503 M | 103.501 M | 115.082 M | 110.403 M | |
| Cost of revenue | 8.197 M | 13.436 M | 9.384 M | 6.942 M | 9.114 M | 9.946 M | 11.324 M | 13.567 M | |
| Gross profit | 72.534 M | 68.255 M | 78.712 M | 79.328 M | 85.389 M | 93.555 M | 103.758 M | 96.836 M | |
| -5.90% | 15.32% | 0.78% | 7.64% | 9.56% | 10.91% | -6.67% | |||
| Operating expenses | 131.698 M | 100.242 M | 118.145 M | 115.456 M | 100.572 M | 106.355 M | 105.268 M | 116.358 M | |
| Selling general and admin | 53.379 M | 47.272 M | 54.274 M | 73.957 M | 65.423 M | 65.651 M | 70.239 M | 88.029 M | |
| Research and development | 78.319 M | 52.970 M | 63.871 M | 41.499 M | 35.149 M | 40.704 M | 35.029 M | 28.329 M | |
| Total expenses | 141.229 M | 114.964 M | 128.840 M | 123.655 M | 111.892 M | 118.529 M | 118.774 M | 132.079 M | |
| -18.60% | 12.07% | -4.02% | -9.51% | 5.93% | 0.21% | 11.20% | |||
| Operating income | -60.498 M | -33.273 M | -40.744 M | -37.385 M | -17.389 M | -15.028 M | -3.692 M | -21.676 M | |
| Ebit | -60.498 M | -33.273 M | -40.744 M | -37.385 M | -17.389 M | -15.028 M | -3.692 M | -21.676 M | |
| Pretax income | -61.246 M | -29.263 M | -70.079 M | -53.219 M | -40.517 M | -24.705 M | -31.660 M | -43.583 M | |
| -52.22% | 139.48% | -24.06% | -23.87% | -39.03% | 28.15% | 37.66% | |||
| Income tax | 911.000 K | 4.023 M | -14.214 M | -287.000 K | 2.715 M | -3.128 M | 2.183 M | 4.836 M | |
| Net income basic | -62.157 M | -33.286 M | -55.865 M | -52.932 M | -43.232 M | -21.577 M | -33.843 M | -48.419 M | |
| 46.45% | -67.83% | 5.25% | 18.33% | 50.09% | -56.85% | -43.07% | |||
| Net income | -62.157 M | -33.286 M | -55.865 M | -52.932 M | -43.232 M | -21.577 M | -33.843 M | -48.419 M | |
| 46.45% | -67.83% | 5.25% | 18.33% | 50.09% | -56.85% | -43.07% |